MONDAY 25 SEPTEMBER

PPR-001 – HMG-CoA reductase inhibitor ameliorates platinum and taxane-induced peripheral neuropathy: a basic research and medical database analysis
Dr Fuka Aizawa1,2, Ms Ami Okabayashi2, Mr Daishi Moriyama2, Dr Kenta Yagi2,3, Dr Shimon Takahashi1, Dr Takahiro Niimura2,3, Dr Mitsuhiro Goda1,2, Dr Yuki Izawa-Ishizawa2,4, Prof Keisuke Ishizawa1,2,3
1Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan, 2Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, 3Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan, 4Department of General Medicine, Taoka Hospital, Tokushima, Japan

PPR-002 A systematic review on persistence with anti-dementia medication and its determinants
Mr Vyasa Murthy Akondi1, Distinguished Professor Gregory M Peterson1, Dr Woldesellassie M Bezabhe1, Dr Mohammed S Salahudeen1
1School of Pharmacy & Pharmacology, University of Tasmania, Hobart, Australia

PPR-003 – Exploring Australian pharmacists’ views towards reducing the risk of medicines-related harm in aged care residents
Mr Sheraz Ali1, Dr Colin Curtain1, Distinguished Professor Gregory Peterson1, Dr Mohammed Salahudeen1
1School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Australia

PPR-004 People’s experiences living with peripheral neuropathy: A qualitative study
Dr Maryam Alkandari1
1University of Reading, Reading, United Kingdom

PPR-005 The experiences of people living with peripheral neuropathy in Kuwait: A process map of the patient journey
Dr Maryam Alkandari1
1University of Reading, Reading , United Kingdom

PPR-006 Leadership competencies and behaviours in pharmacy: A qualitative content analysis
Miss Moudhi Aman1, Dr Naoko Arakawa2, Prof Claire Anderson3
1University of Nottingham, Nottingham , United Kingdom, 2University of Nottingham , Nottingham , United Kingdom, 3University of Nottingham , Nottingham , United Kingdom

PPR-007 Safety and efficacy of apixaban in haemodialysis patients
Ms Sophie Anderson1, Euna Hwang2
1Canberra Health Services, Canberra, Australia, 2Peninsula Health, Victoria, Australia

PPR-008 Developing stakeholder consensus regarding priority pharmaceuticals and environmental risk criteria for formulary decision making: Nominal Group Technique
Dr Naoko Arakawa1, Dr Lydia Niemi2, Prof Claire Anderson1, Dr Mark A. Taggart2, Prof Stuart Gibb2, Prof Sharon Pfleger3
1University of Nottingham, Nottingham, United Kingdom, 2Environmental Research institute, University of Highland and Islands, Thurso, United Kingdom, 3NHS Highland, Inverness, United Kingdom

PPR-009 Effects of human albumin infusion on the prevention and treatment of hyponatremia in patients with liver cirrhosis
Zhaohui Bai1,2, Prof Gang Cheng1
1Shenyang Pharmaceutical University, Shenyang, China, 2General Hospital of Northern Theater Command, Shenyang, China

PPR-010 Who is going to do what?: the reallocation of pharmacy activities for the French pharmacy technicians.
Perrine Louvier1, Mathieu Granjon1, Dr Jean Didier Bardet1
1Univ. Grenoble Alpes, School of Pharmacy, Grenoble, France

PPR-011 Exploration of the medication and health-related goals of care of older people with polypharmacy
Mr Aagam Bordia1, Professor Sarah Hilmer2, Prof Parisa Aslani1, Dr Lisa O’Donnell1
1Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia, , Australia, 2Departments of Clinical Pharmacology and Ageing, Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, Sydney, NSW, Australia , , Australia

PPR-012 A study on safe use of drugs in older adults attending a tertiary care hospital using BEER’s and STOPP criteria
Dr Revathi Boyina1, Dr R Kavya1
1Qis College Of Pharmacy, Ongole, India

PPR-013 Drug-herb interactions and cancer treatment
Ms Jocelin Chan, Dr Jeffry Adiwidjaja1, Prof Andrew McLachlan1, Professor Alan Body2, Dr Joanna Harnett1
1Faculty of Medicine and Health School of Pharmacy, The University of Sydney, Sydney, Australia, 2Clinical & Health Sciences, University of South Australia,, Adelaide, Australia

PPR-014 Agile response to the epidemic-pharmaceutical department of a regional hospital in Taiwan
Ph D. Pharmacist ShuMi Chen1, Pharmacist Wen Chun Wen Chun1
1Lo-hsu Foundation, Inc., Lotung Poh-ai Hospital, Yilan, Taiwan China

PPR-015 Cost-effectiveness analysis of first-line nivolumab plus ipilimumab combination therapy for unresectable malignant pleural mesothelioma: based on a multicenter, phase 3 trial
Dr Zhaoyan Chen1
1West China Hospital, Sichuan University, Chengdu, China

PPR-016 Cost-effectiveness analysis of modified gemcitabine combined with oxaliplatin in unresectable gallbladder cancer in China
Dr Zhaoyan Chen1
1West China Hospital, Sichuan University, Chengdu, China

PPR-017 Enhancing early detection and management of lung cancer: A pharmacist-led lung health assessment and triage initiative
Mrs Simmie Chung1, Professor Bandana Saini, Dr Irene Um
1University Of Sydney, Sydney, Australia

PPR-018 Evaluating the impact of an interprofessional education curriculum on pharmacy graduates in Canada
Prof Della Croteau1, Dr Jamie Kellar1, Ms Heather Abela1, Natalie Crown1, David Rojas Gualdron1, Sylvia Langlois1
1University Of Toronto, Toronto, Canada

PPR-019 Estimation of price variability of different brands of antihypertensive medications in community pharmacies in Kumasi
Dr Mercy Naa Aduele Opare-Addo1, Dr Afia Frimpomaa Asare Marfo1, Dr Vivian Hammond2, Dr Josephine Mensah3, Dr Pauline Boachie-Ansah1, Dr Samuel Darko3
1Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, PMB, UPO, Kumasi, Ghana, 2Juaben Government Hospital, P. O. Box 34, Juaben, Ashanti Region, Ghana, 3Clinical and Inpatient Pharmacy Department, University of Ghana Medical Centre, P. O. Box LG 25, Legon, Accra, Ghana

PPR-020 – Consumer Co-design of Medication Safety Interventions and Services in Primary Care: A Scoping Review
Mrs Megan Deldot1,2, Dr Esther Lau1, Dr Jean Spinks2, A/Prof Fiona Kelly3, Ms Nicole Rayner2, Prof Lisa Nissen2
1Queensland University of Technology, Brisbane, Australia, 2University of Queensland, Brisbane, Australia, 3Griffith University, Gold Coast, Australia

PPR-021 An international comparison of deprescribing interventional studies: How to determine factors that contribute to translational deprescribing success?
Ms Youmna Elsedfy1, Dr Dee Mangin2, Dr Hamish Jamieson3, Mr Ulrich Berger3, Dr Prasad Nishtala4, Ms Susan Weaver, Dr Emily Reeve5, Dr Christopher Freeman1, Dr Nagham Ailabouni1
1The University Of Queensland, Brisbane, Australia, 2McMaster University, Hamilton ON, Canada, 3University of Otago, Dunedin, New Zealand, 4University of Bath, Bath, England, 5Monash University, Melbourne, Australia

PPR-022 Remote medication-related interventions to reduce readmission rate in hospitals: A systematic review
Dr Fatemeh Emadi1, Dr Racha Dabliz2, Prof Rebekah Moles1, Dr Stephen Carter1, Dr Jonathan Penm1, TIC TOC Team
1Faculty of Medicine and Health, School of Pharmacy, The University of Sydney,, Sydney, Australia, 2Australian Commission on Safety and Quality in Health Care, Sydney, Australia

PPR-023 Cost utility analysis of a nosocomial denosumab versus zoledronic acid treatment for bone related events in breast cancer
Mr Caifu Fang1, Ms Yunhui Zhang1, Ms Tao Liu1, Ms Weiting Liang1, Ms Zhuojia Chen1, Mr Hongbing Huang1
1Sun Yat-sen University Cancer Center, Guangzhou, China

PPR-024 Exploring the barriers and enablers to pharmacists-led services in people with disability; Perspectives of pharmacists and disability caregivers
Mrs Chelsea FELKAI1
1University of Newcastle, Callaghan, Australia

PPR-025 Pharmacists led population health approach to reduction of cardiovascular disease in Southern Maryland.
Endowed Professor and Associate Dean Magaly Rodriguez de Bittner1, Director of Operations, eHealth Center Sade Osotimehin1, General Associate (Pharmacist) Byron Ma1, Dr Farideh Sistani1, Professor & Vice-Chair, Director BHRT Fadia.T Shaya, Olu Sokan, Caitlin Murphy, Ernest Carter
1University of Maryland, Baltimore, , United States

PPR-026 Attitudes of rheumatoid arthritis patients towards disease modifying antirheumatic drug deprescribing
Ms Lauren Fraser1
1University Of South Australia, Warradale, Australia

PPR-027 Pharmacist interventions to improve hypertension management: from trials to implementation
Dr Viktoria Gastens1, Dr Stefano Tancredi1, Blanche Kiszio2, Dr Cinzia Del Giovane1, Prof Ross Tsuyuki3, Prof Gilles Paradis4, Prof Arnaud Chiolero1, Prof Valérie Santschi2
1Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland, 2La Source, School of Nursing Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland, Lausanne, Switzerland, 3EPICORE Centre, Department of Medicine and Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada, 4School of Population and Global Health, McGill University, Montreal, Canada

PPR-028 Exploring the impact of medication regimen complexity on health-related quality of life in patients with multimorbidity
Mr Begashaw Melaku Gebresillassie1, Mr Abebe Tarekegn Kassaw2
1School of Medicine and Public Health, University of Newcastle, Newcastle, Australia, 2Department of Pharmacy, College of Health Sciences, Woldia University, Woldia, Ethiopia

PPR-029 – Pharmacy education in traditional and complementary medicines – a systematic review
Dr Carolina Oi Lam UNG, Ms Nadin Kbar, Prof Ingrid Gelissen, Prof Parisa Aslani, Prof Lorraine Smith, Dr Joanna Harnett1
1The University Of Sydney, Sydney, Australia

PPR-030 Multidisciplinary pharmaceutical care in patients with cancer_an impact analysis
Mr Wei Ho1, Mr Jia Hua Jiang2
1National Taiwan Univeristy Cancer Center, Taipei, Taiwan China, 2National Yang Ming Chiao Tung University, Taipei, Taiwan China

PPR-031 Supply of voluntary assisted dying medicine through community pharmacy in the Northern Territory for terminally ill patients: Pharmacists’ perspective
Mrs Teena Jacob1, Dr. Robiul Islam1, Mr Samuel Keitaanpaa1
1Charles Darwin University, Tiwi, Australia

PPR-032 Awareness and use of complementary and alternative medicines by adults visiting selected pharmacies in Lagos State
Dr Arinola Eniola Joda1, Ms. Adeola Sikiru1
1Department of Clinical Pharmacy and Biopharmacy, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria

PPR-033 – Who would be a pharmacist? A national representative cross sectional survey of pharmacists and students to explore personality traits and associations with job satisfaction and career outlook
Mr Srinivas Kamath1, Dr Jacinta Johnson, Dr. Deanna Mills, Dr, Amy Page, Miss. Bianca Soo
1University Of South Australia, Adelaide, Australia

PPR-034 Oral anticoagulant use in Australian atrial fibrillation patients with low risk of stroke: a national cohort study
Mr Adane Kefale1, Dr Woldesellassie M Bezabhe1, Distinguished Professor Gregory Peterson1
1University of Tasmania, Hobart, Australia

PPR-035 Pre-post comparison of clinical pharmacist led anticoagulation clinic in cardiac care setting in Pakistan.
Ms Sumaira Khan1
1Tabba Heart Institute, Karachi , Pakistan

PPR-036 – Cross cultural adaptation and validation of the Self-Management Scale from English to Malay among HIV-infected individuals in Malaysia
Ms Wen Wei Chung1, Prof Pauline Lai1,2, Prof Sasheela Sri La Sri Ponnampalavanar41, Associate Professor Thiam Kian Chiew1
1University Malaya, Kuala Lumpur, Malaysia, 2Sunway University, PetalingJaya, Malaysia

PPR-037 Evaluating the safety of deprescribing interventions: Lessons from a patient, family member and clinician directed educational intervention
Cynthia Boyd1, Dr Emily Reeve2,3, Susan Shetterly4, J Powers4, Linda Weffald4, Ariel Green1, Orla Sheehan1,5, Melanie Drace4, Jonathan Norton1, Mahesh Maiyani4, Kathy Gleason4, Jennifer Sawyer4, Matthew Maciejewski6,7, Jennifer Wolff1, C Kraus4, Elizabeth Bayliss4,8
1Johns Hopkins University, Baltimore, United States, 2Monash University, Melbourne, Australia, 3University of South Australia, Adelaide, Australia, 4Kaiser Permanente Colorado, Aurora, United States, 5Royal College of Surgeons in Ireland, Dublin, Ireland, 6Veterans Affairs Medical Center, Durham, United States, 7Duke University Medical Center, Durham, United States, 8University of Colorado, Aurora, United States

PPR-038 Strengthening regulatory structures for Covid-19 vaccine safety surveillance in Nigeria: A capacity building approach
Mr Imoiboho Ekwere Williams1, Pharm. Uchenna Elemuwa2, Pharm Ken Onu2, Pharm Asmau Abubakar2, Pharm. Victoria Etuk1, Mrs Rita Okonkwo1, Dr Hadley Ikwe3
1Institute Of Human Virology Nigeria – International Research Center Of Excellence, ABUJA, Nigeria, 2National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria, 3United States Center for Disease Control and Prevention, Abuja, Nigeria

PPR-039 An environmental scan of patient safety reporting and learning systems in community healthcare for multi-disciplinary teams
Mr Wei Wei1, Ms Eulaine Ma1, Dr Certina Ho1
1Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada

PPR-040- Clinical impact of antibiograms as an intervention to optimise antimicrobial prescribing and patient outcomes – a Systematic Review
Ms Dipti Khatri1, Dr Naz Falconer1, Doctor Soraia De Camargo Catapan1, Professor Len Gray1, Professor David Paterson2, Dr Christopher Freeman1
1University Of Queensland, Brisbane, Australia, 2ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, , Singapore

PPR-041 – Exploring role for antibiogram use in Australian aged care settings: an i-PARIHS- guided qualitative study.
Ms Dipti Khatri1, Dr Naz Falconer1, Professor Len Gray1, Professor David Paterson2, Dr Christopher Freeman1
1University Of Queensland, Brisbane, Australia, 2ADVANCE-ID, Saw Swee Hock School of Public Health, , Singapore

PPR-042 A study of antibiotic residues in beef.
Mr Daniel Kica1
1Mbarara University of Science and Technology , Mbarara , Uganda

PPR-043 Survey on patients’ experience and quality of care/services provided by the new point of care (POC) Warfarin clinic at the heart centre in RIPAS hospital
Dr Nurolaini Kifli1, Ms Nurfaeezah Jeffree1, Ms Hui Ling Ong2
1Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam, 2Ministry of Health, Bandar Seri Begawan, Brunei Darussalam

PPR-044 Development of a mobile health application to manage oral anticoagulation use for patients with concurrent atrial fibrillation and heart failure
Prof Pauline Lai1, Ms Nirmala Jagan1, Professor Kok Han Chee1, Dr Chee Sun Liew1, Dr Noel Thomas3, Ms Jiaa Yinn Tang3
1University Malaya, Kuala Lumpur, Malaysia, 2Sunway University, Sunway City, Malaysia, 3Hospital Kuala Lumpur, Kuala Lumpur, Malaysia

PPR-045 Perceptions and expectations of health professionals regarding the roles of pharmacists in the hospital setting: a qualitative systematic review
Ms Kyung Min Kirsten Lee1, Dr Amy Page2, Mr Sangseo Kim1, Mr Tarik Al-Diery3, Dr Ivanka Koeper4, Ms Isabella Singh1, Ms Deborah Hawthorne2, Dr Jacinta Johnson1,4
1Clinical and Health Sciences Unit, University of South Australia, Adelaide, South Australia, Australia, 2WA Centre for Health and Aging, School of Allied Health, University of Western Australia, Perth, Western Australia, Australia, 3College of Pharmacy, Qatar University, Doha, Qatar, 4SA Pharmacy, Central Adelaide Local Health Network, SA Health, Adelaide, South Australia, Australia

PPR-046 The effectiveness of drug information service for outpatient cancer patients with opioid analgesics use
Ms Tzu Hsuan Liang1, professor Valerie Holton2, Hospital Pharmacy Department – Director Yu Hui Chang3
1National Taiwan University Hospital Hsin-Chu Branch Biomedical park Hospital, Zhubei City, Taiwan China, 2Coalition of Urban and Metropolitan Universities (CUMU), Ave Urbana, United States, 3National Taiwan University Hospital Hsin-Chu Branch , , Taiwan China

PPR-047 Clinical pharmacist in multidisciplinary teams (MDT) participated in the whole-process pharmacy practice of patients with cancer pain
Ms Tao Liu1, Mr Caifu Fang1, Ms Yunhui Zhang1, Ms Weiting Liang1, Ms Ping Chen1, Ms Zhuojia Chen1, Mr Hongbing Huang1
1Sun Yat-sen University Cancer Center, Guangzhou, China

PPR-048 The impact of allopurinol adherence patterns on outcomes in people with gout
Prof Daniel FB Wright1, Ms Toni J.F. Michael2, Mr Jian S. Chan3, Dr Matthew J. Coleshill4, Prof Parisa Aslani2, Professor Dyfrig A Hughes5, Prof Richard O. Day6, Dr Sophie L. Stocker2
1School of Pharmacy, University Of Otago, Dunedin, New Zealand, 2School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia, 3St. Vincent’s Clinical School Campus, Faculty of Medicine, University of New South Wales , Sydney, Australia, 4Black Dog Institute, Faculty of Medicine, University of New South Wales, Sydney, Australia, 5School of Medical and Health Sciences, Bangor University, Bangor, Wales, 6Department of Clinical Pharmacology & Toxicology, St. Vincent’s Hospital , Sydney, Australia

PPR-049 – Opportunities and challenges for promoting pharmacy practice research in China
Mr Hao Lu1, Mr Jie Pan2
1Intemed Hospital Management & Development (Beijing), Beijing, China, 2The Second Affiliated Hospital of Soochow University, Suzhou, China

TUESDAY 26 SEPTEMBER

PPR-050 Professional stigma towards clients with methamphetamine use disorder – A qualitative study
Mr Ali Makki1
1The University Of Sydney, Sydney, Australia

PPR-051 Implementation of diabetes screening and associated factors in community pharmacy
Prof Kevin Mc Namara1, Dr Tesfaye Feyissa1, Prof Vincent L Versace1, Dr Mohammadreza Mohebbi2, Dr Bernadette Mitchell3, Dr Sophy Shih4, Prof Rob Carter5, Professor Ines Krass3
1Deakin Rural Helath, Deakin University, Warrnambool, Australia, 2Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Australia, 3School of Pharmacy, University of Sydney, Sydney, Australia, 4The Kirby Institute, University of New South Wales, Sydney, Australia, 5Deakin Health Economics, Institute of Health Transformation, Faculty of Health, Deakin University, , Geelong , Australia

PPR-052 An evaluation of psychotropic adverse drug event monitoring tools for use in the long-term care facility setting
Ms Brigid McInerney1, Dr Amanda Cross1, Dr Justin Turner1,2, Prof Simon Bell1
1Centre for Medicine Use & Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia, 2Faculty of Pharmacy, University of Montreal , Quebec, Canada

PPR-053 Exploring patient experiences with pharmacy-based test-to-treat influenza-like illness management programs in the United States
Dr Kimberly McKeirnan1, Dr. Kenneth Hohmeier2, Dr. Donald Klepser3, Dr Julie Akers1, Dr Steven Cagas4, Dr. Cameron James4, Dr. Michael Klepser5, Dr. Mitra Sadeghi4
1Washington State University College Of Pharmacy and Pharmaceutical Sciences, Spokane, United States, 2University of Tennessee Health Sciences Center, Nashville, United States, 3University of Nebraska Medical Center College of Pharmacy, Omaha, United States, 4Genetech, San Fransisco, United States, 5Ferris State University, Big Rapids, United States

PPR-054 Voluntary Assisted Dying (VAD) in Queensland (QLD) – a unique collaborative approach in expanding a pharmacist’s scope of practice to provide holistic patient centred, end-of-life care.
Ms Kathleen McLean1,2, Mr Michael Whordley1,2, Ms Elisha Noone1, Prof Elizabeth (Liz) Reymond1
1Metros South Health QVAD, Eight Mile Plains, Australia, 2Metro South Health, QLD Health, Princess Alexandra Hospital, , Australia

PPR-056 Evaluation of healthcare professionals’ knowledge about high alert medication in Mongolia: A cross-sectional study
Prof Erdenetuya Myagmarsuren1,2, Zolzaya Batkhuu1, Tungalagmaa Khatanbaatar2, Prof Enkhjargal Dorjbal1
1School of Pharmacy, MNUMS, Ulaanbaatar, Mongolia, 2Mongolia Japan Hospital, MNUMS, Ulaanbaatar, Mongolia, 3Associations Of Mongolian Pharmaceutical Professionals, Ulaanbaatar, Mongolia

PPR-057 Improvement of medication adherence and discharge medication appropriateness of patients diagnosed with acute coronary syndrome followed by clinical pharmacy interventions in a tertiary care hospital in Sri Lanka.
Mr Yasa Kalum Bagyawantha Nanayakkara Muhandiramalaya1,5, Prof ID Coombes2,4, Prof I Gawarammana5,6, Prof F Mohamed1,3
1Department of Pharmacy, Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya, Sri Lanka, 2School of Pharmacy, University of Queensland, Brisbane, Australia, 3School of Pharmacy, University of Sydney, Sydney, Australia, 4Collaboration of Australian and Sri Lankans for Pharmacy Practice Education and Research (CASPPER), Brisbane, Australia, 5South Asian Clinical Toxicology Research Collaboration, Peradeniya, Sri Lanka, 6Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka

PPR-058 A multisite implementation-efficacy trial of a pharmacist-led collaborative care for Medication Assisted Treatment for Opioid Dependence: Overview and preliminary findings from the EPIC-MATOD trial
Prof Suzanne Nielsen1, Dr Ali Cheetham1, Ms Elizabeth Grist1, Mr John Jackson2, Ms Sarah Lord3, A/Prof Dennis Petrie4, Dr David Jacka5, Ms Kirsty Morgan6
1Monash University, Monash Addiction Research Centre, Melbourne, Australia, 2Centre for Medicine Use and Safety (CMUS), Monash University, Melbourne, Australia, 3Harm Reduction Victoria, Melbourne, Australia, 4Centre for Health Economics, Monash Business School, Monash University, Melbourne, Australia, 5Monash Health Drug and Alcohol Service, Melbourne, Australia, 6Peninsula Health, Frankston, Australia

PPR-059 Overcoming barriers to healthcare: An examination of medicine availability and affordability in South Pacific Island nations
Mr Lachlan Oldfield1, Prof Rebekah Moles, Dr Jonathan Penm
1The University of Sydney, Sydney, Australia

PPR-060 The availability and affordability of insulin within the South Pacific region
Mr Lachlan Oldfield1, Prof Rebekah Moles, Dr Jonathan Penm
1Sydney University, Sydney, Australia

PPR-061 Knowledge of cervical cancer, screening and preventive measures among Ghanaian Women
Dr Mercy Naa Aduele Opare-Addo1, Dr Afia Frimpomaa Marfo1, Ms Mary Ghansah1, Dr Ivan Mozu1, Dr Samuel Darko2, Dr Janet Ameyaw1
1Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, 2University of Ghana Medical Centre, Accra, Ghana

PPR-062 Factors associated with the use of aphrodisiacs among adult male residents in Korle Klottey Municipality
Dr Mercy Naa Aduele Opare-Addo1, Dr Afia Marfo1, Ms Juliet Poku1, Dr Josephine Mensah2, Dr Janice Osei- Donkor3, Dr Samuel Darko2
1Kwame Nkrumah University Of Science And Technology, Kumasi, Ghana, 2Pharmacy Directorate , University of Ghana Medical Centre, Accra , Ghana, 3Pharmacy Department , Tema General Hospital, Tema , Ghana

PPR-063 – Soluble interleukin-2 receptor combined with interleukin-8 is a powerful predictor of future adverse cardiovascular events in patients with acute myocardial infarction
Dr Kunming Pan1, Prof. Qianzhou Lv
1Zhongshan Hospital Fudan University, Shanghai , China

PPR-064 Maternal antibiotic exposure and the risk of developing antenatal depression: Study protocol
Mrs Mahsa Pouranayatihosseinabad1, Ms. Maggie Taylor1, Dr. Jason Hawrelak1, Prof. Gregory M. Peterson1, Dr. Felicity Veal1, Dr. Tristan Ling1, Dr. Mackenzie Williams1, Dr. Megan Whatley2, Dr. Kyan Ahdieh3, Dr. Corinne Mirkazemi1
1School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Australia, 2Department of Obstetrics and Gynaecology, Royal Hobart Hospital, Hobart, Australia, 3Health Hub, Launceston Medical Centre, Launceston, Australia

PPR-065 Can vitamin B6 deficiency contribute to the severity of diabetic peripheral neuropathy? – A cross sectional study
Dr Ranadheer Chowdary Puvvada1, Dr Praveen Devanandan1
1St Peter’s Institute Of Pharmaceutical Sciences, Warangal, India

PPR-066 Assessment of medication-related problems among patients with type 2 diabetes mellitus: A snapshot from United Arab Emirates
Dr Syed Arman Rabbani1, Dr Sathvik B Sridhar2, Dr Khaled Dahabre3, Dr Nadeem Javed4
1RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates, 2RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates, 3RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates, 4Ibrahim Bin Hamad Obaidallah Hospital, Ras Al Khaimah, United Arab Emirates

PPR-067 The new advanced services in community pharmacy, answers to the French public health issues : inspirations from the international
Docteur Guillaume RACLE1, Docteur Luc Besançon1, Professeur Michel Brazier1, Docteur Gilles Bonnefond1, Docteur Jean-Michel Ducrocq1, Docteur Corinne Imbert1, Docteur Marie-Josée Augé-Caumon1
1USPO, Paris, France

PPR-068 The influence of social and individual factors on medicine use in older adults
Ms Eman Rafhi1, Professor Ieva Stupans1, Dr Kate Wang1,2,3
1RMIT University, Melbourne, Australia, 2School of Allied Health, The University of Western Australia, Perth, Autralia, 3Pharmacy department, Alfred Health, Melbourne, Australia

PPR-069 Alterations of glycemic parameters in post-Covid diabetic patients
Ms Gowthami Arikatla, Professor Satheesh S Gottipati, Mr Venkata Jagadeesh Guntur, Ms Haritha Balijireddy, Ms Jhansi Palavalasa, Dr M. Chandra Sekar1
1University Of Findlay, Findlay, United States

PPR-070 Cost-effectiveness of screening for type 2 diabetes in community pharmacy: the Pharmacy Diabetes Screening Trial (PDST)
Dr Sophy Shih1, Prof Kevin Mc Namara2, Professor Ines Krass3, Professor Vincent Versace2, Dr Mohammadreza Mohebbi2, Dr Bernadette Mitchell3, Professor Rob Carter2
1University Of New South Wales, Sydney, New South Wales, Australia, 2Deakin University, Geelong, Victoria, Australia, 3University of Sydney, Sydney, New South Wales, Australia

PPR-071 Trust, relationship and safety
Dr Denise Taylor1, Dr Courtney Addison
1Victoria Univesrity of Wellington, Wellington, New Zealand

PPR-072- Exposure to Hepatis B Virus (HBV) risk factors and uptake of HBV screening and vaccination among Human Immunodeficiency Virus patients at secondary care hospitals in Ilorin, Nigeria
Dr Felicia Esemekiphoraro Williams1, Dr David Ufuoma Adje2, Pharm Winifred Giwa1, Pharm Jane-frances John-benson1, Dr Louis Odeigah3
1Department of Clinical Pharmacy and Pharmacy Practice, University of Ilorin, Ilorin, Nigeria, 2Department of Clinical Pharmacy and Pharmacy Administration, Delta State University, Abraka, Nigeria, 3Department of Clinical Pharmacy and Pharmacy Practice, University of Ilorin, Ilorin, Nigeria, 4Department of Clinical Pharmacy and Pharmacy Practice, University of Ilorin, Ilorin, Nigeria, 5Department of Family Medicine, University of Ilorin, Ilorin, Nigeria

PPR-073 Strengthening patient safety through multilateral collaborations: Lessons from Covid-19 vaccine surveillance in Nigeria.
Mr Imoiboho Ekwere Williams1, Dr. Ahmed Rufai-Garba4, Pharm. Uchenna Elemuwa3, Pharm. Victoria Etuk1, Mr Oyewole Oyedele1, Mrs Queeneth Ogweri4, Pharm Asmau Abubakar3, Ms Grace Erekosima8, Mr Barnabas Akumba6, Mrs Rahmatullah Obansa5, Mrs Angela Abah5, Mrs Margaret Gberikon7, Dr Oxygen Wullar9, Dr Aminu Mohammed2, Mrs Rita Okonkwo1, Dr Hadley Ikwe2, Dr Bassey Okposen4, Prof Alash’le Abimiku1, Mrs Adeyelu Asekun2
1Institute Of Human Virology Nigeria – International Research Center Of Excellence, ABUJA, Nigeria, 2United States Center for Disease Control, Abuja, FCT, Nigeria, Abuja, FCT , Nigeria, 3National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria, 4National Primary Health Care Development Agency (NPHCDA), Abuja, FCT, Nigeria, 5African Field Epidemiology Network, Abuja, Nigeria, 6Health Information Systems Nigeria (HISP) Nigeria, Abuja, Nigeria, 7Maryland Global Initiatives Corporation, Abuja, Nigeria, 8Sydani Group, Abuja, Nigeria, 9World Health Organization, Abuja, Nigeria

PPR-074 Exploration and practice of home-based pharmaceutical care for a elderly patient with chronic diseases provided by community family pharmacists
Dr Haijian Xia1
1The Affiliated Hospital of Yangzhou University, Yangzhou, China

PPR-075 Drug-related problems in liver transplant recipients in the intensive care unit identified during pharmaceutical care and drug consultation: to improve the quality of healthcare
太太 Shi Xiaoping1
1Zhongshan Hospital Fudan University , Shanghai, China

PPR-076 Analysis of the characteristics and risk factors of levofloxacin-induced arrhythmias
Ms Haili Guo1, Pro Daihong GUO1, Pro Man ZHU1, Peng LI1, 博士 An Fu1, Chao LI1, Jingchuang LU1,2
1Department of Pharmacy, Medical Supplies Center of Chinese PLA General Hospital, Beijing, China, 2Chongqing Medical University, College of Pharmacy, Chongqing, China

PPR-077 Light transmittance aggregometry and platelet function analyzer are trusty in evaluating antiplatelet effectiveness, while thromboelastography performs poorly
Dr Tengfei Shao1, Ms Yue Cheng2, Prof Yun Xu2, Prof Wei-hong Ge1
1Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital Of Nanjing University Medical School, Nanjing, China, 2Department of Neurology, Nanjing Drum Tower Hospital, The Affiliated Hospital Of Nanjing University Medical School, Nanjing, China

PPR-078 Assessment of the knowledge, perceptions and readiness level of pharmacists in Indonesia for the implementation of telepharmacy-based pharmaceutical services
Prof Nasrul Wathoni1, Ms Ghina Nadhifah Iftinan2, Mrs Susi Afrianti Rahayu3, Ms Anggun Nurlatifah4, Dr Miski Aghnia Khairinisa4, Prof Keri Lestari4
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia, 2Medication Therapy Adherance Clinic (MTAC), Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia, 3Departement of Pharmacy, Akademi Farmasi Bumi Siliwangi, Bandung, Indonesia, 4Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia

PPR-078 Off-label use of antimicrobials among hospitalized children：A retrospective study of 3406 patients
Mrs Lin Tang1, Hou Ning, Prof Ke Xu1
1Department Of Pharmacy, Shandong Provincial Hospital Affiliated To Shandong First Medical University, China, Jinan, China

WEDNESDAY 27 SEPTEMBER

PPR-080 Breaking the stigma: How community pharmacists are involved in supporting mental health care
Dr Hamzah Alzubaidi1, Dr. Catarina Samorinha1, Prof. Basema Saddik1, Prof. Abduelmula Abdelkarim1, Prof. Eman Abu-Garbieh1, Prof. Karem Alzoubi1
1University Of Sharjah, Sharjah , United Arab Emirates

PPR-081 Development and validation of tools in relation to vaccination in autoimmune inflammatory rheumatic diseases patients
Mr Jonathan Joseph Attard1, Dr Louise Grech1, Prof Lilian M. Azzopardi1
1Department of Pharmacy, Faculty of Medicine and Surgery, University Of Malta, Msida, Malta

PPR-082 Challenges and concerns of type 1 diabetic patients during transitional settings: the pharmacist’s role
Mr Jonathan Vella1, Dr Louise Grech1, Prof Lilian M. Azzopardi1
1Department of Pharmacy, Faculty of Medicine and Surgery,University Of Malta, Msida, Malta

PPR-083 Pharmacists’ new role in the management of opioid use disorder with extended-release buprenorphine administration to patients, a Qualitative Analysis
Ms. Sumaiya Ahsan1, Dr. Nancy Waite1, Dr. Christoph Laeer2, Dr. Atta Abbas3, Dr. Hung Nguyen1, Dr Feng Chang1
1University Of Waterloo, Waterloo, Canada, 2Family First Family Health Team, Ottawa, Canada, 3University of Reading, Reading, United Kingdom

PPR-084 Patient-centered pharmaceutical care for patients with chronic diseases provided by community pharmacists in China. A Scoping Review
Mr Yuanhui Hu1, Mr GuoLin Li1, Dr Feng Chang2, Ms Huiqiao Mai1, Ms Yufen Zheng1, Ms Yuyao Pei1
1China Pharmaceutical University, Nanjing,Jiangsu, China, 2School of Pharmacy, University of Waterloo, Waterloo, Canada

PPR-085 Physicochemical compatibility of sildenafil injection with intravenous drugs used in the neonatal intensive care setting
Ms Thisuri De Silva1, Dr Brioni Moore1, Prof Tobias Strunk2, Mr Michael Petrovski3, Prof Kevin Batty1
1Curtin Medical School, Curtin University, Bentley, Australia, 2Neonatal Directorate, King Edward Memorial Hospital, Child and Adolescent Health Service, Subiaco, Australia, 3Pharmacy Department, King Edward Memorial Hospital, Women and Newborn Health Service, Subiaco, Australia

PPR-086 Drug Use Evaluation in a tertiary hospital in Nigeria based on the World Health Organization (WHO) Indicators: A cross-sectional facility -based design
Pharm Lizzette Ezenekwe1, Dr Brian Ogbonna1, Pharm Sndra Enyi-Okafor1, Prof Charles Okechukwu Esimone1
1Nnamdi Azikiwe University, Awka, Nigeria, Awka, Nigeria

PPR-087 Prevalence and correlates of self-medication among pharmacy, medical and nursing students in a Nigerian university
Pharm. Lizzette Ezenekwe1, Dr Brian Ogbonna1, Pharm Theophilus Enyivuaku1, Dr Maureen Anetoh1, Dr Blessing Umeh1, Dr Izuchukwu Ejie1, Dr Ifeoma Nduka1
1Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria

PPR-088 Sustainable cold chain vaccine delivery
Dr Alice Gilbert1, Ms Michelle Edmonds1, Ms Kara Milne1, Ms Melanie Morrow2, Associate Professor Bhavini Patel1
1NT Health, Northern Territory, Australia, 2National Critical Care and Trauma Response Centre, Northern Territory, Australia

PPR-089 Interprofessional education; Pharmacists supervising medical student research
Dr Alice Gilbert1, Ms Michelle Edmonds1, Dr Gurmeet Singh1,2,3,4, Associate Professor Bhavini Patel1
1NT Health, Northern Territory, Australia, 2Menzies School of Health Research, , Australia, 3Charles Darwin University, , Australia, 4Northern Territory (NT) Medical Program, Flinders NT, Australia, , Australia

PPR-090 Evaluation of remote pharmacist-led outpatient service for geriatric patients on rivaroxaban for nonvalvular atrial fibrillation during the COVID-19 pandemic
Prof Xiaoye Li1
1Zhongshan Hospital, Fudan University, Shanghai, China

PPR-091 Patient perceptions of prices and costs of biological medicines and their significance
BSc (Pharm) Anni Lindholm1, Dr Laura Saarukka1, Dr Kari Linden2
1Social and Clinical Pharmacy, Clinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland, 2Research Unit, University Pharmacy (Yliopiston Apteekki), Helsinki, Finland

PPR-092 Updates on pharmacological intervention for smoking cessation: A systematic review of systematic reviews
Prof Mohamad Haniki Nik Mohamed1, Ms. Atifah Najib Badri Najib2, Dr. Syahrir Zaini3
1International Islamic University Malaysia, Kuantan, Malaysia, 2International Islamic University Malaysia, Kuantan, Malaysia, 3International Islamic University Malaysia, Kuantan, Malaysia

PPR-093 Updates on interventions for electronic cigarette smoking cessation
Prof Mohamad Haniki Nik Mohamed1, Ms. Nurain Afiqah Mohd Aznan2, Dr. Syahrir Zaini3
1International Islamic University Malaysia, Kuantan, Malaysia, 2International Islamic University Malaysia, Kuantan, Malaysia, 3International Islamic University Malaysia, Kuantan, Malaysia

PPR-094 Updates on behavioural interventions for smoking cessation: A systematic review of systematic reviews
Prof Mohamad Haniki Nik Mohamed1, Ms. Nur Syuhada Abqari Luthfi Albert2, Dr. Syahrir Zaini3
1International Islamic University Malaysia, Kuantan, Malaysia, 2International Islamic University Malaysia, Kuantan, Malaysia, 3International Islamic University Malaysia, Kuantan, Malaysia

PPR-095 Evaluating the impact of partnered pharmacist medication charting in the emergency department on time to administer pre-admission time-critical medicines, adverse drug reactions, medication order completeness and venous thromboembolism risk assessment
Dr Tesfay Mehari Atey1, Distinguished Professor Gregory Peterson1, Dr Mohammed Salahudeen1, Dr Barbara Wimmer1
1School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia

PPR-096 Adverse drug reaction-related hospitalisations among people with dementia: implicated drugs and predictors
Ms Anum Zaidi1, Distinguished Professor Gregory Peterson1, Dr Colin Curtain1, Dr Mohammed Salahudeen1
1School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia

PPR-097 Developing a Patient Centred Incident Reporting Medical Device Framework
Mr Julian Fearne1, Ms Julia Catania2, Dr Louise Grech1, Professor Anthony Serracino Inglott1
1University Of Malta, Msida, Malta, 2Malta Medicines Authority, Msida, Malta

PPR-098 Perception of Maltese healthcare professionals on cannabis for medicinal use.
Dr David Zammit Dimech1, Dr Louise Grech1, Professor Anthony Serracino Inglott1
1Department of Pharmacy, Faculty of Medicine and Surgery,University Of Malta, Mosta, Malta

PPR-099 A framework for understanding sources of bias in medication adherence research
Miss Klarissa Sinnappah1, Professor Dyfrig A Hughes2, Dr Sophie L Stocker3,4, Dr Bernard Vrijens5, Professor Jeffrey K Aronson6, Prof Daniel FB Wright1
1School of Pharmacy, University Of Otago, Dunedin, New Zealand, 2Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, Wales, 3Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia, 4Department of Clinical Pharmacology and Toxicology, St Vincent’s Hospital, Sydney, Australia, 5AARDEX Group & Liège University, Liège, Belgium, 6Centre for Evidence-based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

PPR-100 Impact of pharmacy-based interventions for limited health literacy patients with chronic disease: A systematic review
Ms Sumithra Devi Suppiah1,2, Associate Professor Alison Beauchamp1,3,4, Assistant Professor Rahul Malhotra2,5, Associate Professor Lita Sui Tjien Chew6,7, Associate Professor Wern-Ee Tang8,9, Ms Xilei Yang7, Dr Jason Talevski1,3,11, Ms Natali Cvetanovska1,10, Dr Rebecca Leigh Jessup1,12,13,14,15
1Monash University, Victoria, Australia, 2Centre for Ageing Research and Education, Duke-NUS Medical School, Singapore, Singapore, 3Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St Albans, Victoria, Australia, 4Victorian Heart Institute, Monash University, Clayton, Victoria, Australia, 5Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore, 6Department of Pharmacy, National Cancer Centre, Singapore, Singapore, 7Department of Pharmacy, Faculty of Science. National University of Singapore, Singapore, Singapore, 8National Healthcare Group Polyclinics, Singapore , Singapore, 9Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, 10Office of Research, Northern Health, Epping, Victoria, Australia, 11Institute for Physical Activity and Nutrition Research (IPAN), School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia, 12Academic and Research Collaborative in Health, La Trobe University, Bundoora, Victoria, Australia, 13Allied Health Research, Northern Health, Epping, Victoria, Australia, 14Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia, 15Monash Department of Clinical Epidemiology, Cabrini Institute, Victoria , Australia

PPR-101 Provision of vaccination service in the community pharmacy – impact on pharmacists’ job satisfaction and well-being
Dr Wejdan Shahin1, Ms Sandra Jnoub1, Ms Ghufran Al-Khaqane1, Ms Evet Matti1, Ms Kay Dunkley2, Dr Thilini Thrimawithana1
1School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia, 2Pharmacists’ Support Services, Melbourne, Australia

PPR-102 Optimising community pharmacy workflow to enhance professional service implementation: A deprescribing case study
Dr Justin Turner1, Kelda Newfport2, Dr Aili Langford1, Aishling McEvoy1, Prof Cara Tannenbaum3, Dr Deborah Kelly2
1Monash University, Parkville, Australia, 2Memorial University of NewfoundlandUniversite de Montreal , St John’s, Canada, 3Universite de Montreal , St John’sMontreal, Canada

PPR-103 A study of clinical pharmacist-led medication reconciliation practice in cancer patients: A prospective observational study
Dr Boguda Vishwanath Anantharamaiah1, miss Jwan Anna david2, miss Gopika PP2
1Aditya Bangalore Institute Of Pharmacy Education And Research, Bangalore, India, 2Aditya Bangalore Institute Of Pharmacy Education And Research, Bangalore, India, 3Aditya Bangalore Institute Of Pharmacy Education And Research, Bangalore, India

PPR-104 VaxCheck: The development and testing of a clinical decision-making adult vaccine tool for community pharmacists
Prof Nancy Waite1, Dr. Molly Yang2, Dr. Elizabeth Vernon-Wilson1, Dr Lisa Dolovich3, Prof Sherilyn Houle1
1University of Waterloo, Waterloo, Canada, 2Wholehealth Pharmacy Partners, Toronto, Canada, 3University of Toronto, Toronto, Canada

PPR-105 Burnout and resilience in the Singapore pharmacy workforce: National surveys (2023)
Dr Aiwen Wang1,2, Ms Ines Leow1, Ms Varsha D/O Muthayah1, Dr Yu Ke3, Dr Jo Lene Leow5, Mr Jin Jian Chong5, A/Prof Lita Chew1,5
1National University of Singapore (NUS), Singapore, Singapore, 2Singapore General Hospital, Singapore, Singapore, 3National Cancer Center of Singapore, Singapore, Singapore, 4Singapore Health Services, Singapore, Singapore, 5Pharmaceutical Society of Singapore, Singapore, Singapore

PPR-106 Role of the clinical pharmacist in a cardio-oncology multidisciplinary team
Mr Chunhui Wang1, Wei Wu, Jing Li, Qing Xu, Xiaoyu Li, Qianzhou Lv
1Zhongshan Hospital, Fudan University, Shanghai, China

PPR-107 Combination of rivaroxaban and amiodarone increases bleeding in patients with atrial fibrillation
Dr Zi Wang1, Prof Xiaoye Li1, Prof. Qing Xu1, Prof. Xiaoyu Li1, Prof. Qianzhou Lv1
1Zhongshan Hospital, Fudan University, Shanghai, China

PPR-109 What do healthcare providers value the most about collaboration with the School of Pharmacy Clinic at the University of Otago, New Zealand?
Ms Tara Wheeler1, Dr. Sharon Leitch2, Professor Carlo Marra1
1School of Pharmacy, University of Otago, Dunedin, New Zealand, 2General Practice and Rural Health, Otago Medical School, University of Otago, Dunedin, New Zealand

PPR-110 Does insulin-related hypoglycemia depend on the level of the hospital? A study protocol from three government hospitals in Sri Lanka.
Ms. Wickramasinghe NDD1, Ms. Bandara WEWMRTW2, Ms. Jayasundara M3, Ms. Samarakoon SMS4, Ms. Rathnaweera Bopage Janani Buddhika1
1Faculty of Health Sciences, The Open University of Sri Lanka, Colombo, Sri Lanka, 2T.H. Peradeniya, , Sri Lanka, 3B.H. Homagama, , Sri Lanka, 4D.H. Rideegama, , Sri Lanka

PPR-111 Living with cystic fibrosis: what role does the pharmacist play?
Ms Heidi Wong1, Miss Bernadette Gerzanics1, Dr Sonya Stacey1
1Queensland Children’s Hospital Pharmacy, Brisbane, Australia

PPR-112 Preliminary exploration study of colorectal cancer pharmacist outpatient clinic based on information collaboration platform
Professor Li Xiaoyan1, Clinical Pharmacy JIGNWEN XIE1, Clinical Pharmacy XIAOYAN HUANG1
1The Sixth Affiliated Hospital,Sun Yat-sen University, Guangzhou, china

PPR-113 The efficacy and cost-effectiveness of physician-pharmacist collaborative clinics for T2DM management in primary healthcare centers: A multicenter randomized controlled trial
Ms Jie Xiao1,2, Ms Shuting Huang1,2, 教授 Ping Xu1,2
1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China, 2Institute of Clinical Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China

PPR-114 A new score for predicting intracranial hemorrhage in patients using anticoagulant drugs
Mr. Fuxin Ma1, Mr. Wenlin Xu, Mr. Chengfu Guan1, Prof Jinhua Zhang1
1Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China

PPR-115 The Alfalfa-inpatient-CAT assessment model: a thrombotic risk assessment model for inpatient oncology patients
Mrs. Shijie Chang1, Mrs. Shuyi Wu1, Mrs. Jiana Chen1, Prof Jinhua Zhang1
1Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fuj, Fuzhou, China

PPR-116 New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants from a multicenter real-world study in China
Mr. Fuxin Ma1, Mr. Chengfu Guan1, Mr. Wenlin Xu1, Prof Jinhua Zhang1
1Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fuj, Fuzhou, China

PPR-117 A systematic review of self-medication practice during the COVID-19 pandemic: implications for pharmacy practice in supporting public health measures
Ms Yu Zheng1, Ms Jiayu Liu1, Ms Pou Kuan Tang1, Prof Hao Hu1,2,3, Dr Carolina Oi Lam UNG1,2,3
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China, Macao, China, 2Centre for Pharmaceutical Regulatory Sciences, University of Macau, Macao SAR, China, Macao, China, 3Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Macao SAR, China, Macao, China

PPR-118 Research on medication errors in children based on adverse drug reaction reporting database（FAERS）
Dr Hailong Li1,2,3,4, Ms Panda Qiu1,2,3,4,5, Mr YuanMing Ni1,2,3,4,5, Prof Liang Huang1,2,3,4,5, Prof Lei Zhang6, Prof Wei Zhang7,8, Prof Lingli Zhang1,2,3,4,5
1West China Second University Hospital, Sichuan University, Chengdu, China, 2Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China, 3Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China, 4NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu, China, 5West China School of Pharmacy, Sichuan University, Chengdu, China, 6College of Computer Science, Sichuan University, Chengdu, China, 7West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China, 8 Medical Big Data Center, Sichuan University, Chengdu, China

PPR-119 – A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs
Prof Jinhua Zhang1, Mr. Fuxin Ma1, Mrs. Shijie Chang1, Mr. Chengfu Guan1
1Fujian Maternity and Child Health Hospital, Fuzhou, China